Moderna: Fade 2025 Outlook (NASDAQ:MRNA)

Maddie Meyer Along with the overall stock market, Moderna (NASDAQ:MRNA) had a big liftoff towards the end of 2023. The biotech company promoted a 2025 turnaround story, but the market jumped onto the more bullish view far too soon. My investment thesis remains Bearish on Moderna with more Covid vaccine sales pain ahead and questions…

Read More

Rivian Stock: Fade The Rally (NASDAQ:RIVN)

Doucefleur The RIVN Investment Thesis Remains Viable, But With Some Patience We previously covered Rivian Automotive (NASDAQ:RIVN) in July 2023, discussing its surprising FQ2’23 production and delivery report, well exceeding its FQ1’23 numbers. Despite our previous scepticism, it appeared that we had been proven wrong then. For now, thanks to the delivery beats, RIVN has…

Read More

U.S. Recession Risk For Q3 Continues To Fade

sefa ozel It’s been clear for some time that US recession risk has been sliding in recent months, but this week’s updates of a widely followed GDP nowcast published by the Atlanta Fed has been revised up – a lot – for the third quarter. According to this model, the US economy isn’t just rolling…

Read More